WPD Pharmaceuticals Inc.

CNSX:WBIO Stock Report

Market Cap: CA$579.9k

WPD Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

CNSX:WBIO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Nov 24SellCA$3,160Caelum Finance Ltd, Asset Management ArmCompany632,000CA$0.005
07 Nov 24SellCA$5Caelum Finance Ltd, Asset Management ArmCompany1,000CA$0.005
03 Oct 24SellCA$5Caelum Finance Ltd, Asset Management ArmCompany1,000CA$0.005
30 Sep 24SellCA$5Caelum Finance Ltd, Asset Management ArmCompany1,000CA$0.005
19 Sep 24SellCA$5Caelum Finance Ltd, Asset Management ArmCompany1,000CA$0.005
10 Sep 24SellCA$1,820Caelum Finance Ltd, Asset Management ArmCompany364,000CA$0.005
27 Aug 24SellCA$5,994Caelum Finance Ltd, Asset Management ArmCompany1,200,000CA$0.005

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of WBIO?
Owner TypeNumber of SharesOwnership Percentage
Institutions00%
Private Companies12,083,52210.4%
Individual Insiders25,963,64622.4%
General Public77,939,96967.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.


Top Shareholders

Top 5 shareholders own 32.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.7%
Waldemar Priebe
24,043,467CA$120.2k0%no data
10.4%
Triple G Ventures, Llc
12,083,522CA$60.4k0%no data
1.15%
Mariusz Olejniczak
1,334,401CA$6.7k0%no data
0.39%
Peter Novak
453,778CA$2.3k0%no data
0.11%
Teresa Rzepczyk
132,000CA$660.00%no data